skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Details
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:058957/0597   Pages: 4
Recorded: 02/04/2022
Attorney Dkt #:345620-2000
Conveyance: CHANGE OF ADDRESS FOR ASSIGNEE
Total properties: 43
1
Patent #:
NONE
Issue Dt:
Application #:
11703401
Filing Dt:
02/06/2007
Publication #:
US20090018142
Pub Dt:
01/15/2009
Title:
Use of phosphatases to treat tumors overexpressing N-CoR
2
Patent #:
7998957
Issue Dt:
08/16/2011
Application #:
12069147
Filing Dt:
02/06/2008
Publication #:
US20090036309
Pub Dt:
02/05/2009
Title:
OXABICYCLOHEPTANES AND OXABICYLCOHEPTENES, THEIR PREPARATION AND USE
3
Patent #:
NONE
Issue Dt:
Application #:
12221360
Filing Dt:
08/01/2008
Publication #:
US20090035292
Pub Dt:
02/05/2009
Title:
Use of phosphatases to treat neuroblastomas and medulloblastomas
4
Patent #:
8143445
Issue Dt:
03/27/2012
Application #:
12286769
Filing Dt:
10/01/2008
Publication #:
US20090143445
Pub Dt:
06/04/2009
Title:
HDAC INHIBITORS
5
Patent #:
8227473
Issue Dt:
07/24/2012
Application #:
12460404
Filing Dt:
07/17/2009
Publication #:
US20100029484
Pub Dt:
02/04/2010
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
6
Patent #:
NONE
Issue Dt:
Application #:
12460407
Filing Dt:
07/17/2009
Publication #:
US20100029683
Pub Dt:
02/04/2010
Title:
Methods for regulating cell mitosis by inhibiting serine/threonine phosphateses
7
Patent #:
8058268
Issue Dt:
11/15/2011
Application #:
12462182
Filing Dt:
07/29/2009
Publication #:
US20100029640
Pub Dt:
02/04/2010
Title:
NEUROPROTECTIVE AGENTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES
8
Patent #:
8426444
Issue Dt:
04/23/2013
Application #:
13174249
Filing Dt:
06/30/2011
Publication #:
US20120270736
Pub Dt:
10/25/2012
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
9
Patent #:
8329719
Issue Dt:
12/11/2012
Application #:
13195626
Filing Dt:
08/01/2011
Publication #:
US20110287537
Pub Dt:
11/24/2011
Title:
NEUROPROTECTIVE AGENTS FOR THE PREVENTION AND TREATMENT OF NEURODEGENERATIVE DISEASES
10
Patent #:
NONE
Issue Dt:
Application #:
13378623
Filing Dt:
02/17/2012
Publication #:
US20120135522
Pub Dt:
05/31/2012
Title:
METHODS OF MODULATING CELL REGULATION BY INHIBITING P53
11
Patent #:
8455688
Issue Dt:
06/04/2013
Application #:
13426417
Filing Dt:
03/21/2012
Publication #:
US20120178783
Pub Dt:
07/12/2012
Title:
HDAC INHIBITORS
12
Patent #:
8541458
Issue Dt:
09/24/2013
Application #:
13493816
Filing Dt:
06/11/2012
Publication #:
US20120264764
Pub Dt:
10/18/2012
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
13
Patent #:
8822461
Issue Dt:
09/02/2014
Application #:
13866854
Filing Dt:
04/19/2013
Publication #:
US20130302402
Pub Dt:
11/14/2013
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
14
Patent #:
9526915
Issue Dt:
12/27/2016
Application #:
13870763
Filing Dt:
04/25/2013
Publication #:
US20130280210
Pub Dt:
10/24/2013
Title:
METHODS FOR REGULATING CELL MITOSIS BY INHIBITING SERINE/THREONINE PHOSPHATASE
15
Patent #:
NONE
Issue Dt:
Application #:
14119849
Filing Dt:
04/24/2014
Publication #:
US20140235649
Pub Dt:
08/21/2014
Title:
USE OF PHOSPHATASE INHIBITORS OR HISTONE DEACETYLASE INHIBITORS TO TREAT DISEASES CHARACTERIZED BY LOSS OF PROTEIN FUNCTION
16
Patent #:
9079917
Issue Dt:
07/14/2015
Application #:
14328384
Filing Dt:
07/10/2014
Publication #:
US20150045373
Pub Dt:
02/12/2015
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
17
Patent #:
NONE
Issue Dt:
Application #:
14408208
Filing Dt:
12/15/2014
Publication #:
US20150174123
Pub Dt:
06/25/2015
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF REPERFUSION INJURY
18
Patent #:
10149847
Issue Dt:
12/11/2018
Application #:
14408475
Filing Dt:
12/16/2014
Publication #:
US20150148353
Pub Dt:
05/28/2015
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
19
Patent #:
NONE
Issue Dt:
Application #:
14772317
Filing Dt:
09/02/2015
Publication #:
US20160008336
Pub Dt:
01/14/2016
Title:
HDAC INHIBITORS FOR THE TREATMENT OF TRAUMATIC BRAIN INJURY
20
Patent #:
10532050
Issue Dt:
01/14/2020
Application #:
14783360
Filing Dt:
10/08/2015
Publication #:
US20160051544
Pub Dt:
02/25/2016
Title:
FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES
21
Patent #:
NONE
Issue Dt:
Application #:
14852219
Filing Dt:
09/11/2015
Publication #:
US20160074390
Pub Dt:
03/17/2016
Title:
HUMAN DOSING OF PHOSPHATASE INHIBITOR
22
Patent #:
NONE
Issue Dt:
Application #:
15036760
Filing Dt:
05/13/2016
Publication #:
US20160264593
Pub Dt:
09/15/2016
Title:
PROTEIN PHOSPHATASE INHIBITORS THAT CROSS THE BLOOD BRAIN BARRIER
23
Patent #:
9833450
Issue Dt:
12/05/2017
Application #:
15048389
Filing Dt:
02/19/2016
Publication #:
US20160303115
Pub Dt:
10/20/2016
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DEPRESSIVE AND STRESS DISORDERS
24
Patent #:
9988394
Issue Dt:
06/05/2018
Application #:
15154304
Filing Dt:
05/13/2016
Publication #:
US20160333024
Pub Dt:
11/17/2016
Title:
OXABICYCLOHEPTANE PRODRUGS
25
Patent #:
NONE
Issue Dt:
Application #:
15320153
Filing Dt:
12/19/2016
Publication #:
US20170136008
Pub Dt:
05/18/2017
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF OVARIAN CANCER
26
Patent #:
10071094
Issue Dt:
09/11/2018
Application #:
15328235
Filing Dt:
06/29/2017
Publication #:
US20170340628
Pub Dt:
11/30/2017
Title:
PROTEIN PHOSPHATASE 2A INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROMES
27
Patent #:
NONE
Issue Dt:
Application #:
15385357
Filing Dt:
12/20/2016
Publication #:
US20170259081
Pub Dt:
09/14/2017
Title:
METHODS FOR REGULATING CELL MITOSIS BY INHIBITING SERINE/THREONINE PHOSPHATASE
28
Patent #:
10023587
Issue Dt:
07/17/2018
Application #:
15425550
Filing Dt:
02/06/2017
Publication #:
US20170369503
Pub Dt:
12/28/2017
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
29
Patent #:
9994584
Issue Dt:
06/12/2018
Application #:
15518282
Filing Dt:
04/11/2017
Publication #:
US20170305925
Pub Dt:
10/26/2017
Title:
PROCESS OF SYNTHESIZING 3-(4-METHYLPIPERAZINE-1-CARBONYL)-7-OXABICYCLO[2.2.1] HEPTANE-2-CARBOXYLIC ACID
30
Patent #:
NONE
Issue Dt:
Application #:
15589485
Filing Dt:
05/08/2017
Publication #:
US20170240558
Pub Dt:
08/24/2017
Title:
SANGUINARINE ANALOG PP2C INHIBITORS FOR CANCER TREATMENT
31
Patent #:
10413541
Issue Dt:
09/17/2019
Application #:
15816372
Filing Dt:
11/17/2017
Publication #:
US20180256565
Pub Dt:
09/13/2018
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DEPRESSIVE AND STRESS DISORDERS
32
Patent #:
10364252
Issue Dt:
07/30/2019
Application #:
15968462
Filing Dt:
05/01/2018
Publication #:
US20180244690
Pub Dt:
08/30/2018
Title:
OXABICYCLOHEPTANE PRODRUGS
33
Patent #:
10399993
Issue Dt:
09/03/2019
Application #:
16018924
Filing Dt:
06/26/2018
Publication #:
US20180370983
Pub Dt:
12/27/2018
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES, THEIR PREPARATION AND USE
34
Patent #:
NONE
Issue Dt:
Application #:
16072963
Filing Dt:
07/26/2018
Publication #:
US20190111053
Pub Dt:
04/18/2019
Title:
CLINICAL REGIMEN FOR TREATING MYELODYSPLASTIC SYNDROME WITH PHOSPHATASE INHIBITOR
35
Patent #:
10434100
Issue Dt:
10/08/2019
Application #:
16105479
Filing Dt:
08/20/2018
Publication #:
US20190046525
Pub Dt:
02/14/2019
Title:
PROTEIN PHOSPHATASE 2A INHIBITORS FOR TREATING MYELODYSPLASTIC SYNDROMES
36
Patent #:
10668062
Issue Dt:
06/02/2020
Application #:
16206390
Filing Dt:
11/30/2018
Publication #:
US20190167671
Pub Dt:
06/06/2019
Title:
OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES FOR THE TREATMENT OF DIABETES
37
Patent #:
10618908
Issue Dt:
04/14/2020
Application #:
16439227
Filing Dt:
06/12/2019
Publication #:
US20190359627
Pub Dt:
11/28/2019
Title:
OXABICYCLOHEPTANE PRODRUGS
38
Patent #:
NONE
Issue Dt:
Application #:
16467721
Filing Dt:
06/07/2019
Publication #:
US20200069680
Pub Dt:
03/05/2020
Title:
OXABICYCLOHEPTANES FOR MODULATION OF IMMUNE RESPONSE
39
Patent #:
11931354
Issue Dt:
03/19/2024
Application #:
16705699
Filing Dt:
12/06/2019
Publication #:
US20200179375
Pub Dt:
06/11/2020
Title:
FORMULATIONS OF OXABICYCLOHEPTANES AND OXABICYCLOHEPTENES
40
Patent #:
NONE
Issue Dt:
Application #:
16770136
Filing Dt:
06/05/2020
Publication #:
US20210275521
Pub Dt:
09/09/2021
Title:
OXABICYCLOHEPTANES FOR TREATMENT OF SECONDARY ACUTE MYELOID LEUKEMIA
41
Patent #:
11236102
Issue Dt:
02/01/2022
Application #:
16782970
Filing Dt:
02/05/2020
Publication #:
US20200325151
Pub Dt:
10/15/2020
Title:
OXABICYCLOHEPTANE PRODRUGS
42
Patent #:
NONE
Issue Dt:
Application #:
17252160
Filing Dt:
12/14/2020
Publication #:
US20210379106
Pub Dt:
12/09/2021
Title:
OXABICYCLOHEPTANES FOR ENHANCING CAR T CELL FUNCTION
43
Patent #:
11866444
Issue Dt:
01/09/2024
Application #:
17586548
Filing Dt:
01/27/2022
Publication #:
US20220235066
Pub Dt:
07/28/2022
Title:
OXABICYCLOHEPTANE PRODRUGS
Assignor
1
LIXTE BIOTECHNOLOGY, INC.
Exec Dt:
02/01/2022
Assignee
1
LIXTE BIOTECHNOLOGY, INC.
680 EAST COLORADO BLVD., SUITE 180
PASADENA, CALIFORNIA 91101
Correspondence name and address
COOLEY LLP
1299 PENNSYLVANIA AVENUE NW, SUITE 700
DC, WA 20004

Search Results as of: 05/14/2024 07:13 PM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT